Stuart Pollack

Dr. Stuart Pollack is a registered patent attorney who concentrates his practice on patent litigation, as well as patent prosecution and counseling and opinion work.

With over 16 trials argued in federal court, 9 appeals, and several cases at the Patent Trials and Appeals Board, Stuart has helped obtain favorable judgments in several suits on behalf of pioneer drug companies, including suits brought under the Hatch-Waxman Act against potential generic entrants. His extensive work has focused on pharmaceutical products and drug substances, polymers, optics and chemical reactors, and he has also worked on cases involving mechanical inventions.

Stuart has successfully represented companies in suits before the International Trade Commission. He has also helped obtain patents for his clients in pharmaceutical and chemical technology at the Patent and Trademark Office.
Prior to joining the firm, Stuart was a partner in the New York City office of an international law firm where he focused on patent litigation. Previously, Stuart was a partner in a law firm based in New York City.

Stuart has published more than a dozen peer-reviewed papers involving metal clusters and nanotechnology for scholarly journals such as those published by the American Physical Society.

Stuart was recognized as a “Life Sciences Star” by The Legal Media Group in 2018 and previously in 2014, he was noted as one of a few preeminent Life Science practitioners in the U.S. Stuart has been listed by the IAM Patent 1000 and was named a 2018 New York “Super Lawyer” by Super Lawyers magazine. He was recognized as a national “Star” by Euromoney / Institutional Investor’s 2009 Benchmark: America’s Leading Litigation Firms and Attorneys in the area of Intellectual Property. Additionally, he has been recognized by Legal 500 US.

Education

Admissions